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Abstract: Polyphenols are found ubiquitously in plants and their regular consumption has 
been associated with a reduced risk of a number of chronic diseases, including cancer, 
cardiovascular disease (CVD) and neurodegenerative disorders. Rather than exerting direct 
antioxidant  effects,  the  mechanisms  by  which  polyphenols  express  these  beneficial 
properties appear to involve their interaction with cellular signaling pathways and related 
machinery that mediate cell function under both normal and pathological conditions. We 
illustrate that their interactions with two such pathways, the MAP kinase (ERK, JNK, p38) 
and PI3 kinase/Akt signaling cascades, allow them to impact upon normal and abnormal 
cell  function,  thus  influencing  the  cellular  processes  involved  in  the  initiation  and 
progression of cancer, CVD and neurodegeneration. For example, their ability to activate 
ERK in neurons leads to a promotion of neuronal survival and cognitive enhancements, 
both of which influence the progression of Alzheimer’s disease, whilst ERK activation by 
polyphenols in vascular endothelial cells influences nitric oxide production, blood pressure 
and ultimately CVD risk. The main focus of this review is to provide an overview of the 
role  that  polyphenols  play  in  the  prevention  of  cancer,  cardiovascular  disease  and 
neurodegeneration. We present epidemiological data, human intervention study findings, as 
well as animal and in vitro studies in support of these actions and in each case we consider 
how their actions at the cellular level may underpin their physiological effects. 
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1. Introduction 
Epidemiological studies suggest that high dietary intake of polyphenols is associated with decreased 
risk of a range of diseases including cardiovascular disease (CVD), specific forms of cancer [1] and 
neurodegenerative diseases [2]. In particular, a group of polyphenols known as flavonoids have been 
strongly linked with beneficial effects in many human, animal and in vitro studies [3]. With respect to 
cardiovascular health, flavonoids may alter lipid metabolism [4], inhibit low-density lipoprotein (LDL) 
oxidation  [5],  reduce  atherosclerotic  lesion  formation  [6]  inhibit  platelet  aggregation  [7],  decrease 
vascular cell adhesion molecule expression [8], improve endothelial function [9] and reduce blood 
pressure [10]. However, flavonoids have also been shown to exert beneficial cognitive effects and to 
reverse specific age-related neurodegeneration [11] and to exert a variety of anti-carcinogenic effects, 
including an ability to induce apoptosis in tumor cells [12-14], inhibit cancer cell proliferation [15,16] 
and prevent angiogenesis and tumor cells invasion [17]. This review will detail the evidence for the 
role of polyphenols in the context of these three chronic diseases and where relevant, the probable 
modes by which they exert their activity in vivo.  
2. Polyphenols and Cancer  
Cancer refers to a group of diseases that are associated with a disturbance in the control of cell 
growth and  metabolism [18]. Indeed, the unbalanced control of  cellular proliferation is a primary 
characteristic of cancer cells and, as such, any molecule capable of inhibiting cancer cell proliferation 
may also be useful as a potential chemo-preventive agent [19-22]. There are many different types of 
cancer, although breast (predominately women), lung, colorectal and prostate cancer accounts for over 
half of all new cases. It is widely believed that a high daily intake of fruit and vegetables helps to 
prevent the onset of, and progression of, cancer. Over the past 20 years, case-control studies have 
indicated an inverse correlation between regular fruit and vegetable consumption and the development 
of various types of cancer [23,24]. More recently, data from large cohort investigations have gone 
some  way  to  confirm  these  epidemiological  associations  [25-29].  However,  there  is  a  degree  of 
controversy, in that some studies have reported no reduction in bladder, pancreatic and stomach cancer 
incidence due to fruit and vegetables intake [30-32] and a recent epidemiological study has provided 
evidence for no, or little, association between fruit and vegetable intake and overall cancer risk [25,33]. 
Despite this, it remains a possibility that specific fruits or vegetables, or specific polyphenols found 
within  these,  may  exert  protective  effects  against  cancer  development,  particularly  in  the 
gastrointestinal tract where they will be at highest concentration. In fact, many studies have shown that 
various  polyphenol-rich  fruits  and  vegetables  are  particularly  effective  in  protecting  against  colon 
cancer development [34,35]. 
At the cellular level, there is good evidence that polyphenols present in tea, red wine, cocoa, fruit 
juices, and olive oil influence carcinogenesis and tumor development [36]. For example, they may Nutrients 2010, 2  
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interact with reactive intermediates [37] and activated carcinogens and mutagens [38], may modulate 
the  activity  of  key  proteins  involved  in  controlling  cell  cycle  progression  [39]  and  influence  the 
expression of many cancer-associated genes [40]. Perhaps most notably, the anticancer properties of 
green tea flavanols have been reported in animal models [41], human cell lines [42], as well as in 
human  intervention  studies  [43].  Furthermore,  green  tea  consumption  has  been  proposed  to 
significantly reduce the risk of cancer of the biliary tract [44], bladder [45], breast [46] and colon [47]. 
Many  of  the  anti-cancer  properties  associated  with  green  tea  are  believed  to  be  mediated  by  the 
flavanol, epigallocatechin gallate (EGCG),  which  has  been  shown to  induce apoptosis and inhibit 
cancer cell growth by altering the expression of cell cycle regulatory proteins and the activity of 
signaling proteins involved in cell proliferation, transformation and metastasis [48]. In addition to 
flavonoids, phenolic alcohols, lignans and secoiridoids (all found at high concentration in olive oil) are 
also thought to induce anti-carcinogenic effects [49] and have been reported in large intestinal cancer 
cell models [50], in animals [51,52] and in humans [49]. These effects may be mediated by the ability 
of  olive  oil  phenolics  to  inhibit  the  initiation,  promotion  and  metastasis  in  human  colon 
adenocarcinoma cells [53,54] and to down-regulate the expression of COX-2 and Bcl-2 proteins that 
have a crucial role in colorectal carcinogenesis [50] (Figure 1). 
Polyphenols may exert these anticancer effects via a variety of mechanisms, including removal of 
carcinogenic agents [37,49], modulation of cancer cell signaling [48,55] and cell cycle progression 
[15,16], promotion of apoptosis [12-14] and modulation of enzymatic activities [56]. For example, the 
enhancement  of  glutathione  peroxidase,  catalase,  NADPH-quinone  oxidoreductase,  glutathione  
S-transferase and/or cytochrome P450 enzyme activity by polyphenols may aid in the detoxification of 
carcinogenic agents [57]. Furthermore, they may modulate the activity of signaling pathways [58-60] 
(i.e., MAPK kinase and PI3 Kinase), which are involved in cancer cell proliferation  [61-63]. The 
MAPK signaling pathway has long been viewed as an attractive pathway for anticancer therapies, 
based on its central role in regulating the growth and survival of cells from a broad spectrum of human 
cancers  [64],  and  its  role  in  the  transcriptional  and  post-transcriptional  activation  of  COX-2  [65] 
(Figure 1). In this context, certain polyphenols have been shown to exert a strong inhibitory effect on 
the growth of colon adenocarcinoma cells through the inhibition of p38/CREB signaling, a decrease in 
COX-2  expression  and  the  stimulation  of  a  G2/M  phase  cell  cycle  block  [55].  In  addition, 
hydroxytyrosol  [66], epicatechin and dimer B2  [67] have  been  shown to  strongly inhibit ERK1/2 
phosphorylation and downstream cyclin D1 expression leading to a block in cell cycle progression 
(Figure 1). Alternatively, polyphenols such as hydroxytyrosol and tea flavanols such as EGCG have 
been  shown  to  reduce  COX-2  over-expression,  which  is  associated  with  colorectal  neoplasia  in 
colorectal cancer [68-71]. 
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Figure  1.  The  interaction  of  polyphenols  with  cellular  signaling  pathways  involved  in 
chronic disease. Flavonoid-induced activation and/or inhibition of MAP kinase and PI3 
kinase  signaling  leads  to  the  activation  of  transcription  factors  which  drive  gene 
expression. For example, activation of ERK/Akt and the downstream transcription factor 
CREB by flavonoids may promote changes in neuronal viability and synaptic plasticity, 
which ultimately influence neurodegenerative processes. Polyphenol-induced inhibition of 
the JNK, ASK1 and p38 pathways leads to inhibition of both apoptosis in neurons and a 
reduction of neuroinflammatory reactions in microglia (reduced iNOS expression and NO• 
release).  Alternatively, their  interaction  with  signaling  may  lead  to  direct  activation  of 
proteins such as eNOS, which controls nitric oxide release in the vasculature and thus 
influences CVD risk. 
 
Tumors are also characterized by an increase in glucose uptake and a high rate of glycolysis, which 
can led to the non-enzymatic glycation of proteins and the generation of so called advanced glycation 
end products (AGEs). Indeed, the measurement of the AGEs, N
Є-carboxymethyllysine (CML) and 
argpyrimidine in several human tumors has been linked to their involvement in cancer progression 
[72]. Certain polyphenols have been proposed to counteract AGE formation both in vivo and in vitro 
and thus may limit their impact on the carcinogenesis process [73-76]. Furthermore, receptors for 
AGEs, such as RAGE, have also been recognized to play an important role in regulating cancer cell 
invasion and metastasis [77,78] (Figure 2) and flavanols such as EGCG may inhibit the cancer cell 
proliferation by blocking RAGE related signaling [79].  Nutrients 2010, 2  
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Figure  2.  Formation  of  Advanced  Glycation  Endproducts  (AGEs)  and  the  sites  where 
flavonoids may inhibit their formation (*). These include monosaccharide autoxidation, 
glycation, glycoxidation, as well as AGE receptor binding, which results in the activation 
and release of inflammation mediators. 
 
3. Polyphenols and Cardiovascular Disease 
Cardiovascular disease (CVD), in particular coronary heart disease and stroke, is a major cause of 
mortality in developed nations [80]. CVD is a chronic, multi-factorial disease in which a range of 
genetic  and  environmental  factors  plays  a  role  in  its  initiation,  progression and  development.  For 
example,  smoking,  high  saturated  fat  diets  and  physical  inactivity  are  well  known  environmental 
factors that are known to increase the risk of CVD [81-84]. This array and variety of factors makes it 
difficult to explore the impact that an individual factor, for example a specific dietary nutrient, has on 
the progression of CVD. Despite this, numerous epidemiological and human intervention studies have 
suggested that regular consumption of polyphenol-rich foods, such as fruits, vegetables, cocoa, tea and 
wine,  may  exert cardio-protective effects in humans [85-94]. Prospective studies have indicated a 
correlation between the intake of flavonols, flavones and flavanols and a reduced risk of coronary 
artery disease [95] and anthocyanin and flavanone intake and reduced CVD related mortality [90]. 
Furthermore, meta-analyses have indicated that the consumption of three cups of tea per day reduces 
CVD risk by 11% [96] and regular, moderate red wine consumption is associated with a 32% reduced Nutrients 2010, 2  
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risk of CVD [97]. However, there remains significant debate over which polyphenols are active, or 
most active, in the context of CVD. Indeed, a recent systematic review has concluded that soy and 
cocoa flavonoids have the most beneficial effect on reducing cardiovascular risk [98], whilst other 
polyphenols are ineffective [87,99-101]. The reasons for these inconsistencies may relate to a number 
of factors, including the use of different dietary intake questionnaires and food composition tables, 
differences  in  the  levels  and  types  of  polyphenols  studied  and  differences  in  the  populations 
investigated, such as well-nourished populations and populations with high polyphenol intake showing 
no effect [102]. 
Various  human,  animal  and  cell  studies  have  suggested  that  polyphenols  may  exert  beneficial 
effects on the vascular system via an induction of antioxidant defenses [103-105], by lowering blood 
pressure  [98,106-111],  by  improving  endothelial  function  [108,112-121],  by  inhibiting  platelet 
aggregation  [107,122-124]  and  low  density  lipoprotein  oxidation  [105,125]  and  by  reducing 
inflammatory responses [126,127]. A daily intake of flavanol containing cocoa was found to be the 
causal factor in determining the relatively low incidence of hypertension and CVD incidence in the 
Kuna Amerinds of the San Blas Island in Panama [128]. In support of these findings, three recent 
meta-analyses  have  confirmed  the  blood  pressure  lowering  capacity  of  flavanol-rich  cocoa 
[98,106,110]. Whilst a correlation between high black tea consumption and decreased blood pressure 
has been reported [129,130], the effects of tea polyphenols have proved less consistent, with reports 
indicating  they  both  reduce  blood  pressure  [131]  or  have  no  effect  in  animal  models  [132]. 
Furthermore, unlike those studies with cocoa, human intervention studies investigating the short-term 
effect of tea consumption on blood pressure have failed to show positive effects [133-136] and there are 
inconsistent data with regards to the effect of red wine or grapes on blood pressure [88,89,111,137-140]. 
However, in general there is a growing body of evidence to support the short-term and long-term 
benefits  of  cocoa,  purple  grape  juice,  tea  and  red  wine  consumption  with  regards  to  endothelial 
function and CVD risk [104,108,112-115,133,135,141-145].  
One suggested mechanism for the action of polyphenols on vascular function involves their ability 
to modulate the levels of and activity of nitric oxide synthase (eNOS) and therefore nitric oxide (NO) 
bioavailability to the endothelium [112,146-150] (Figure 1). In support of this, aortic ring experiments 
using  physiological  concentrations  of  polyphenols  have  shown  that  polyphenols  induce  
endothelium-dependent relaxation [148,151-156]. This regulation of vascular nitric oxide is thought to 
involve  the  ability  of  polyphenols  to  interact  with  kinase  signaling  pathways  such  as  the  
PI3-kinase/Akt  pathway  and  intracellular  Ca
+2  on  eNOS  phosphorylation  and  subsequent  NO 
production [157,158] (Figure 1). As well as activating eNOS, many polyphenols have also been shown 
to increase eNOS expression, to induce prostacyclin production, to inhibit endothelin-1 and endothelial 
NADPH oxidase [149,159-162] and to inhibit angiogenesis and the migration and proliferation of 
vascular cells and matrix metalloproteinase (MMP) activation [158]. They have also been proposed to 
inhibit platelet aggregation [163,164] with cocoa, purple grape juice, red wine, black tea, coffee and 
berry  interventions  all  effective  in  acutely  and  chronically  inhibiting  platelet  activation  and 
aggregation [107,122,123,164-169]. Lastly, flavanols and flavonols may act to prevent AGE-related 
vascular  injury  [170,171]  via  their  regulation  of  MAPK  signaling  through  RAGE  [172]  and  the  
down-regulation  of  transcription  factors  such  as  NF-kB  leading  to  the  suppression  of  NADPH 
oxidase [173] (Figure 1).  Nutrients 2010, 2  
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4. Polyphenols and Neurodegeneration 
Neurodegenerative disorders such as Parkinson’s and Alzheimer’s diseases represent an increasing 
problem in our aging societies, primarily as there is an increased prevalence of both Alzheimer’s 
disease [174,175] and Parkinson’s disease [175-177] with age. These and other neurodegenerative 
disorders appear to be triggered by multi-factorial events including neuroinflammation, glutamatergic 
excitotoxicity, increases in oxidative stress, iron and/or depletion of endogenous antioxidants [178-180]. 
In terms of dietary modulation of these diseases, epidemiological studies have suggested that moderate 
wine consumption may reduce the incidence of certain age-related neurological disorders including 
Alzheimer’s  disease  [181-183].  Furthermore,  regular  dietary  intake  of  flavonoid-rich  foods  and/or 
beverages has been associated with 50% reduction in the risk of dementia [184], a preservation of 
cognitive performance with ageing [185,186], a delay in the onset of Alzheimer’s disease [187] and a 
reduction in the risk of developing Parkinson’s disease [2]. 
Many studies have reported the bioavailability of polyphenols in the systemic circulation [188-191]. 
Whilst less is known regarding their degree of brain bioavailability, flavanones such as hesperetin, 
naringenin and their in vivo metabolites, have been shown to traverse the BBB in relevant in vitro and 
in  situ  models  [192].  Moreover,  several  anthocyanins  have  also  been  identified  in  the cortex  and 
cerebellum of rat [193] and pig [194,195] following feeding with blueberries. Together, these results 
suggest that polyphenols are able to transverse the BBB, albeit to varying degrees depending on their 
structure.  Thus,  such  compounds  are  likely  to  be  candidates  for  direct  neuroprotective  and 
neuromodulatory actions. 
Flavonoids may act to protect the brain in a number of ways, including by protection of vulnerable 
neurons, the enhancement of existing neuronal function or by stimulating neuronal regeneration [196]. 
For  example,  polyphenols  have  been  shown  to  protect  neurons  against  oxidative  stress  [197]  and  
Aβ-induced-induced  neuronal  injury  [198]  and  polyphenol-rich  Ginkgo  biloba  extracts  have  been 
shown  to  be  neuroprotective  [199]  by  protecting  hippocampal  neurons  from  nitric  oxide-  and  
beta-amyloid-induced neurotoxicity [200]. Furthermore, anthocyanins and isoflavones [201,202] may 
be capable of reducing the neurodegeneration associated with the accumulation AGEs during normal 
[203] and abnormal brain ageing [204]. In the context of Parkinson’s disease, the citrus flavanone 
tangeretin has been observed to maintain nigro-striatal integrity and functionality following lesioning 
with 6-hydroxydopamine, suggesting that it may serve as a potential neuroprotective agent against the 
underlying pathology associated with Parkinson’s disease [205]. In addition to the neuroprotection 
elicited by flavonoids, phenolic compounds such as caffeic acid and tyrosol has also been shown to 
protect against 5-S-cysteinyl-dopamine [206] and peroxynitrite neurotoxicity [207] in vitro.  
There is also a growing interest in the potential of polyphenols to improve memory, learning and 
general cognitive ability [208-211]. Human investigations have suggested that fruits and vegetables 
may have an impact on memory [212-214] and depression [215] and there is a large body of animal 
behavioral evidence to suggest that berries, in particular blueberries and strawberries, are effective at 
reversing age-related deficits in spatial working memory [216-221], in improving object recognition 
memory [222] and in  modulating inhibitory fear conditioning [220,221]. The beneficial effects of 
flavonoid-rich foods and beverages on psychomotor activity in older animals have also been reported 
[217,223]. In addition to berries, tea [35,224], pomegranate [225], Ginkgo biloba [226-235] and pure Nutrients 2010, 2  
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flavonols such as quercetin, rutin [236] and fisetin [237] have also been shown to be beneficial in 
reversing neuronal and behavioral aging. Furthermore, Ginkgo biloba has been shown to promote 
inhibitory  avoidance  conditioning  in  rats  with  high-dose  intake  leading  to  short-term,  but  not  
long-term, passive avoidance learning in senescent mice [238,239].  
The  effects  of  polyphenols  on  cognition  and  against  neurodegenerative  processes  appear  to  be 
mediated via their interactions with neuronal and glial signaling pathways that affect gene expression 
and interfere with the cell death mechanisms [233,234]. For example, flavonoids may exert direct 
modulation of protein and lipid kinase signaling pathways [209,232,234], via the inhibition of MAPK 
signaling cascades, such as p38 or ERK1/2 [226,240] (Figure 1). The effects of flavonoids on these 
kinases  may  influence  downstream  transcription  factors  [240],  including  nuclear  factor-Kappa  B  
(NF-κB) [202,241], which responds to p38 signaling and is involved in iNOS induction [242]. This 
suggests that there may be interplay between signaling pathways, transcription factors and cytokine 
production in determining the neuroinflammatory response in the CNS (Figure 1). In addition, the 
actions of flavonoids on neuronal signaling may mediate their ability to protect against neurotoxicity 
induced by AGEs [243]. 
5. Summary 
Polyphenols  are  found  ubiquitously  in  plants  and  are  therefore  consumed  in  relatively  high 
quantities in the human diet. Over the last 20 years, a significant amount of data has emerged with 
regards to the  potential health  effects  of several classes of  polyphenolic compounds,  in  particular 
flavonoids. Along with this, reasonable understandings of the bioavailability of polyphenols and the 
mechanisms by which they exert such benefits in vivo have been determined. These mechanisms are 
now  believed  to  involve  interactions  with  a  number  of  cellular  signaling  pathways,  which  are 
important in the normal functioning of cells. Such interactions appear to modulate these pathways in a 
way that acts to control various pathogenic processes relevant to chronic disease progression. In this 
respect,  polyphenols,  in  particular  flavonoids  structurally  resemble  inhibitors  of  cell  signaling 
cascades, such as the PD98059, a MAPK inhibitor and the LY294002, a phosphatidylinositol-3 kinase 
(PI3) inhibitor. Indeed, the latter inhibitor was modeled on the structure of quercetin [244]. LY294002 
and quercetin fit into the ATP binding pocket of the enzyme and it appears that the number and 
substitution of hydroxyl groups on the B ring and the degree of un-saturation of the C2-C3 bond are 
important determinants of this particular bioactivity. In this regard, quercetin and some of its in vivo 
metabolites have been suggested to inhibit Akt/protein kinase B (PKB) signaling pathways [245], a 
mechanism of action consistent with quercetin and its metabolites acting at and inhibiting PI3-kinase 
activity. Although we have gained a better understanding of how polyphenols interact with cells, there 
is still a long way to go before the precise cellular targets and mechanisms of action can be established. 
While  various  lines  of  evidence  via  biomarker  assessments  and  the  use  of  pharmacological  tools 
in vivo  (i.e.,  specific  enzyme  inhibitors,  receptor  agonists  or  antagonist)  have  indicated  several 
potential mechanisms of action, a comprehensive proof and conclusive understanding has yet to be 
established. This relates mainly to significant limitations with regard to current data from  in vitro 
investigations that aimed at elucidating the mechanisms of action by which polyphenols exert their 
bioactivities in vivo. It is notable that in most cases, in vitro data with regards to polyphenol bioactivity Nutrients 2010, 2  
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have been derived via the direct use of plant/food extracts or isolated native compounds, a practice that 
does not take into account the processes of absorption and metabolism that polyphenols undergo in 
humans. As such, one should express caution when interpreting the wealth of in vitro data linking 
numerous polyphenols to actions in the body and effects against various disease processes, especially 
if no data has been collected regarding the action of physiological metabolites of polyphenols in the 
same cell systems. For example, if there is no evidence for the absorption of a particular polyphenol in 
humans, can one really gain meaningful insight into its biological effects by exposing it to cultured 
cells  of  the  cardiovascular  system  and/or  brain?  There  are  specific  exceptions,  for  example  the 
gastrointestinal tract, where polyphenols may come into direct contact with the cells without having 
undergone absorption and metabolism. Therefore, it is perhaps relevant to investigate the effects of 
polyphenols  and  polyphenol  extracts  on  colon  cancer  cells,  although  as  the  gut  microbiota  also 
extensively  metabolizes  them  one  must  take  account  of  these  effects  prior  to  concluding  on  a 
mechanism  of  action  in  vivo.  These  and  other  limitations  significantly  hamper  the  translation  of 
in vitro  data  on  the  biological  effects  of  flavanols  and  procyanidins  into  meaningful  insight  and 
mechanistic understanding of the in vivo effects in humans. 
Whilst  the  case  for  the  biological  functions  of  polyphenols  in  humans  is  accumulating,  there 
remains insufficient evidence to claim clear and undisputed positive health effects relating to their 
consumption,  particularly  with  regards  to  long-term  dietary  ingestion  and  human  health. 
Epidemiological  studies  have  failed  to  show  conclusive  results, in  some  cases  due  to  the  lack  of 
appropriate nutrient databases and/or the use of an inappropriately controlled study population. Much 
of the strongest data, particularly with regards to CVD, is based on short-term human studies, in many 
cases lacking appropriate controls and a defined polyphenol content of the foods assessed. In addition 
to  better-defined  human  intervention  studies  aimed  at  assessing  physiological  endpoints  linked  to 
disease, further research is also required regarding the bioavailability of polyphenols, particularly with 
regards to the effects of food matrices on absorption and the influence on age, gender and genotype on 
both absorption and metabolism These studies are required in order to help determine the physiological 
metabolic forms responsible for activity in vivo, as well as to help define adequate biomarkers of 
polyphenol  intake.  Therefore,  at  present,  while  the  vast  literature  regarding  the  potential  of 
polyphenols  to  improve  in  human  health  is  encouraging, more  long-term,  randomized,  controlled, 
dietary  intervention  trials  with  appropriate  controls  are  warranted  in  order  to  assess  the  full  and 
unequivocal role that polyphenols play in preventing chronic human disease. The outcomes of these 
studies may ultimately be used to make specific dietary recommendations regarding the efficacy of 
polyphenols in preventing chronic disease risk and to fully validate polyphenols as the new agents 
against various chronic human diseases.  
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